CITIC Securities Maintains "BUY" Rating on ALI HEALTH (00241), Expected to Benefit from Online Migration Trend in Pharmaceutical Retail
Stock News
Sep 24
CITIC Securities released a research report stating that as the National Medical Insurance Administration strengthens its review of medical insurance fund usage at pharmacies, ALI HEALTH's (00241) pharmaceutical e-commerce business is expected to significantly benefit from the online migration trend in pharmaceutical retail. Meanwhile, during this process, the company's traceability code business can provide core technical support. The company is steadily advancing testing work for its "Hydrogen Ion" medical Q&A platform, with AI applications in pharmaceutical search and recommendation scenarios improving service experience and enhancing operational efficiency. The firm maintains its "BUY" rating.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.